Disease applications of spinal cord stimulation: Chronic nonmalignant pain

Francesco Sammartino,Jacquelyn MacDonell,Richard B North,Vibhor Krishna,Lawrence Poree,Richard B. North
DOI: https://doi.org/10.1016/j.neurot.2023.e00314
IF: 6.088
2024-04-01
Neurotherapeutics
Abstract:Neuropathic pain is a chronic condition representing a significant burden for society. It is estimated 1 out of 10 people over the age of 30 that in the US have been diagnosed with neuropathic pain. Most of the available treatments for neuropathic pain have moderate efficacy over time which limit their use; therefore, other therapeutic approaches are needed for patients. Spinal cord stimulation is an established and cost-effective modality for treating severe chronic pain. In this article we will review the current approved indications for the use of spinal cord stimulation in the US and the novel therapeutic options which are now available using this therapy.
pharmacology & pharmacy,neurosciences,clinical neurology
What problem does this paper attempt to address?